370 related articles for article (PubMed ID: 30909778)
1. Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.
Song YH; Seo EH; Yoo YS; Jo YI
Ren Fail; 2019 Nov; 41(1):72-79. PubMed ID: 30909778
[TBL] [Abstract][Full Text] [Related]
2. Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
Thompson Bastin ML; Adams PM; Nerusu S; Morris PE; Mayer KP; Neyra JA
Blood Purif; 2022; 51(2):122-129. PubMed ID: 33915554
[TBL] [Abstract][Full Text] [Related]
3. Is parenteral phosphate replacement in the intensive care unit safe?
Agarwal B; Walecka A; Shaw S; Davenport A
Ther Apher Dial; 2014 Feb; 18(1):31-6. PubMed ID: 24267593
[TBL] [Abstract][Full Text] [Related]
4. Phoxilium vs Hemosol-B0 for continuous renal replacement therapy in acute kidney injury.
Chua HR; Schneider AG; Baldwin I; Collins A; Ho L; Bellomo R
J Crit Care; 2013 Oct; 28(5):884.e7-14. PubMed ID: 23683569
[TBL] [Abstract][Full Text] [Related]
5. Preventing Continuous Renal Replacement Therapy-Induced Hypophosphatemia: An Extended Clinical Experience with a Phosphate-Containing Solution in the Setting of Regional Citrate Anticoagulation.
Pistolesi V; Zeppilli L; Polistena F; Sacco MI; Pierucci A; Tritapepe L; Regolisti G; Fiaccadori E; Morabito S
Blood Purif; 2017; 44(1):8-15. PubMed ID: 28219057
[TBL] [Abstract][Full Text] [Related]
6. An Institutional Change in Continuous Renal Replacement Therapy: Nutrition Support Team Resolves Resultant Severe Hypophosphatemia.
Busch RA; Curtis CS; Kight CE; Leverson GE; Ma Y; Maursetter L; Kudsk KA
Nutr Clin Pract; 2017 Apr; 32(2):245-251. PubMed ID: 29927525
[TBL] [Abstract][Full Text] [Related]
7. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
[TBL] [Abstract][Full Text] [Related]
8. An Institutional Change in Continuous Renal Replacement Therapy.
Busch RA; Curtis CS; Kight CE; Leverson GE; Ma Y; Maursetter L; Kudsk KA
Nutr Clin Pract; 2017 Apr; 32(2):245-251. PubMed ID: 27589256
[TBL] [Abstract][Full Text] [Related]
9. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children.
Santiago MJ; López-Herce J; Urbano J; Bellón JM; del Castillo J; Carrillo A
Kidney Int; 2009 Feb; 75(3):312-6. PubMed ID: 19002217
[TBL] [Abstract][Full Text] [Related]
10. Predictions of Serum Phosphate Concentration during Continuous Renal Replacement Therapy Using a Steady-State Mass Balance Model.
Leypoldt JK; Echeverri J; Harenski K; Singh K
Blood Purif; 2024; 53(1):40-48. PubMed ID: 37926075
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hypophosphatemia during continuous renal replacement therapy-An overlooked problem.
Heung M; Mueller BA
Semin Dial; 2018 May; 31(3):213-218. PubMed ID: 29405468
[TBL] [Abstract][Full Text] [Related]
12. Reductions in red blood cell 2,3-diphosphoglycerate concentration during continuous renal replacment therapy.
Sharma S; Brugnara C; Betensky RA; Waikar SS
Clin J Am Soc Nephrol; 2015 Jan; 10(1):74-9. PubMed ID: 25538269
[TBL] [Abstract][Full Text] [Related]
13. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Hypophosphatemia and Outcomes during Continuous Renal Replacement Therapy.
Hendrix RJ; Hastings MC; Samarin M; Hudson JQ
Blood Purif; 2020; 49(6):700-707. PubMed ID: 32320987
[TBL] [Abstract][Full Text] [Related]
15. Impact of electrolyte-rich dialysate during continuous renal replacement therapy on serum phosphate and potassium in ICU patients.
Cho A; Lee YK; Park HC
PLoS One; 2020; 15(9):e0238867. PubMed ID: 32915900
[TBL] [Abstract][Full Text] [Related]
16. Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies.
Pistolesi V; Zeppilli L; Fiaccadori E; Regolisti G; Tritapepe L; Morabito S
J Nephrol; 2019 Dec; 32(6):895-908. PubMed ID: 31515724
[TBL] [Abstract][Full Text] [Related]
17. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.
Broman M; Carlsson O; Friberg H; Wieslander A; Godaly G
Acta Anaesthesiol Scand; 2011 Jan; 55(1):39-45. PubMed ID: 21039362
[TBL] [Abstract][Full Text] [Related]
18. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy.
Troyanov S; Geadah D; Ghannoum M; Cardinal J; Leblanc M
Intensive Care Med; 2004 Aug; 30(8):1662-5. PubMed ID: 15156308
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury.
Demirjian S; Teo BW; Guzman JA; Heyka RJ; Paganini EP; Fissell WH; Schold JD; Schreiber MJ
Nephrol Dial Transplant; 2011 Nov; 26(11):3508-14. PubMed ID: 21382993
[TBL] [Abstract][Full Text] [Related]
20. Association of Serum Phosphate Derangement With Mortality in Patients on Continuous Renal Replacement Therapy.
Thongprayoon C; Radhakrishnan Y; Cheungpasitporn W; Petnak T; Qureshi F; Mao MA; Kashani KB
Can J Kidney Health Dis; 2022; 9():20543581221114697. PubMed ID: 35923184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
